Hillenbrand (HI) officer discloses new RSU grants and 8,903 owned shares

Rhea-AI Filing Summary

Hillenbrand, Inc. insider equity update: A senior executive, identified as an officer serving as Sr. VP & President, MTS, reported equity holdings and new deferred equity awards in a Form 4 filing. Following the reported activity, the executive directly beneficially owns 8,903 shares of Hillenbrand common stock.

The filing details several grants of restricted stock units (RSUs) effective 12/31/2025, including deferred stock awards of 61, 17, 53 and 241 RSUs, and Matching RSUs of 8 and 16 units, all with a $0 exercise price. Each RSU represents the contingent right to receive one share of common stock and carries dividend equivalent rights. The awards vest in tranches between 2024 and 2028 under scheduled vesting dates and the company’s Executive Share Match framework, with settlement in shares or cash depending on vesting conditions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morytko Tamara

(Last) (First) (Middle)

ONE BATESVILLE BOULEVARD

(Street)

BATESVILLE IN 47006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hillenbrand, Inc. [ HI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP & President, MTS

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								8,903	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Deferred Stock Award 09/11/2023)	(1)	12/31/2025		A(2)		61		(3)	(3)	Common Stock	61	$0	8,629	D
Restricted Stock Units (Deferred Stock Award 12/7/2023)	(1)	12/31/2025		A(2)		17		(4)	(4)	Common Stock	17	$0	2,393	D
Restricted Stock Units (Deferred Stock Award 12/5/2024)	(1)	12/31/2025		A(2)		53		(5)	(5)	Common Stock	53	$0	7,524	D
Restricted Stock Units (Matching RSU Framework 03/31/2025)	(1)	12/31/2025		A(2)		8		(6)	(6)	Common Stock	8	$0	1,243	D
Restricted Stock Units (Matching RSU Framework 10/1/2025)	(1)	12/31/2025		A(2)		16		(7)	(7)	Common Stock	16	$0	2,264	D
Restricted Stock Units (Deferred Stock Award 12/4/2025)	(1)	12/31/2025		A(2)		241		(8)	(8)	Common Stock	241	$0	33,888	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

3. Restricted Stock Units scheduled to vest one-quarter on 9/11/2024, one-quarter on 9/11/2025, and one-half on 9/11/2026.

4. Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026.

5. Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027.

6. Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028, and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.

7. Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on October 1, 2028, and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.

8. Restricted Stock Units scheduled to vest one-third on 12/4/2026, one-third on 12/4/2027, and one-third on 12/4/2028.

Remarks:

	/s/ Allison A. Westfall, Attorney-in-Fact for Tamara Morytko	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity at Hillenbrand (HI) is disclosed in this Form 4?

The filing reports equity holdings and new restricted stock unit awards for a Hillenbrand officer serving as Sr. VP & President, MTS, as of a 12/31/2025 transaction date.

How many Hillenbrand (HI) common shares does the reporting person now beneficially own?

After the reported transactions, the officer directly beneficially owns 8,903 shares of Hillenbrand common stock.

What types of derivative securities are reported for the Hillenbrand (HI) insider?

The filing lists multiple restricted stock units (RSUs), including deferred stock awards and Matching RSUs granted under the Executive Share Match framework.

What RSU amounts were granted to the Hillenbrand (HI) officer on 12/31/2025?

The reported RSU grants effective 12/31/2025 include deferred stock awards of 61, 17, 53, and 241 RSUs, plus Matching RSUs of 8 and 16 units, each representing one share of common stock.

Do the Hillenbrand (HI) restricted stock units carry dividend rights?

Yes. The RSUs are entitled to dividend equivalent rights, which accrue on dividend record dates.

When do the Hillenbrand (HI) deferred stock award RSUs vest?

The deferred RSUs have scheduled vesting over several years, including tranches on 9/11/2024, 9/11/2025, 9/11/2026, and on 12/7/2024, 12/7/2025, 12/7/2026, as well as 12/5/2025, 12/5/2026, and 12/5/2027, and 12/4/2026, 12/4/2027, and 12/4/2028.

What are the key dates for Hillenbrand (HI) Matching RSUs under the Executive Share Match framework?

The Matching RSUs are scheduled to vest on March 31, 2028 and October 1, 2028, and will be settled in common stock or cash if the framework’s vesting conditions are satisfied.